ZA200900237B - Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them - Google Patents
Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising themInfo
- Publication number
- ZA200900237B ZA200900237B ZA200900237A ZA200900237A ZA200900237B ZA 200900237 B ZA200900237 B ZA 200900237B ZA 200900237 A ZA200900237 A ZA 200900237A ZA 200900237 A ZA200900237 A ZA 200900237A ZA 200900237 B ZA200900237 B ZA 200900237B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparations
- salts
- pharmaceutical compositions
- aminopyrazolopyridines
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06090109A EP1867648A1 (en) | 2006-06-13 | 2006-06-13 | Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200900237B true ZA200900237B (en) | 2010-03-31 |
Family
ID=37075752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200900237A ZA200900237B (en) | 2006-06-13 | 2009-01-12 | Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1867648A1 (xx) |
CN (1) | CN101528742A (xx) |
ZA (1) | ZA200900237B (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2042500A1 (en) * | 2007-09-21 | 2009-04-01 | Bayer Schering Pharma Aktiengesellschaft | N-[4-(1-H-pyrazolo[3,4-c]pyridin-4-yl)phenyl]-N'-[(hetero)aryl]-urea compounds, pharmaceutical compositions comprising them, their preparation and their use as Tie2-kinase inhibitors |
UY30796A1 (es) * | 2006-12-15 | 2008-07-31 | Bayer Schering Pharma Ag | 3-h-pirazolopiridinas y sales de éstas, composiciones farmacéuticas que las comprenden, métodos para prepararlas, y sus usos |
US8846673B2 (en) | 2009-08-11 | 2014-09-30 | Bristol-Myers Squibb Company | Azaindazoles as kinase inhibitors and use thereof |
CN103923078A (zh) * | 2013-01-15 | 2014-07-16 | 华东理工大学 | 3,4-二取代(1H-吡唑[3,4-b]吡啶)类化合物及其用途 |
WO2017152117A1 (en) | 2016-03-03 | 2017-09-08 | Cornell University | Small molecule ire1-alpha inhibitors |
JOP20190024A1 (ar) | 2016-08-26 | 2019-02-19 | Gilead Sciences Inc | مركبات بيروليزين بها استبدال واستخداماتها |
CN108117551B (zh) * | 2016-11-29 | 2020-03-27 | 华东理工大学 | 取代(1H-吡唑[3,4-b]吡啶)脲类化合物及其抗肿瘤用途 |
WO2018161033A1 (en) * | 2017-03-02 | 2018-09-07 | Wright, Adrian | Small molecule ire1-alpha inhibitors |
KR102526964B1 (ko) | 2018-02-26 | 2023-04-28 | 길리애드 사이언시즈, 인코포레이티드 | Hbv 복제 억제제로서의 치환된 피롤리진 화합물 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4115394A (en) * | 1974-05-06 | 1978-09-19 | E. R. Squibb & Sons, Inc. | Amino derivatives of 6-phenylpyrazolo[3,4-b]pyridines |
ATE469888T1 (de) * | 2003-05-22 | 2010-06-15 | Abbott Lab | Indazol-, benzisoxazol- und benzisothiazol- kinaseinhibitoren |
JP5112875B2 (ja) * | 2004-10-29 | 2013-01-09 | アボット・ラボラトリーズ | 新規なキナーゼ阻害薬 |
-
2006
- 2006-06-13 EP EP06090109A patent/EP1867648A1/en not_active Withdrawn
-
2007
- 2007-06-12 CN CNA2007800302103A patent/CN101528742A/zh active Pending
-
2009
- 2009-01-12 ZA ZA200900237A patent/ZA200900237B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1867648A1 (en) | 2007-12-19 |
CN101528742A (zh) | 2009-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL195813A0 (en) | Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them | |
IL242883B (en) | Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them | |
IL204521A0 (en) | Oxadiazole derivatives, their preparation and pharmaceutical compositions containing them | |
IL199397A (en) | Hetero-ring compounds, pharmaceuticals containing them, and their medicinal products | |
IL195488A (en) | Compounds, pharmaceuticals containing them and their uses | |
IL203578A (en) | History of pyrimidine-4 - carboxamide, their preparation and their pharmaceutical preparations | |
IL193772A0 (en) | 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same | |
IL203915A (en) | Annotations of 2-Benzylphenyl-6-Hydroxymethyl-Tetrahydro-2 H-Pyrene-3,4,5-Triol | |
IL190292A (en) | History of pyridopyrimidinone and their pharmaceutical preparations | |
IL204442A (en) | Inhibitors of atpase-0fif, medicinal preparations containing them and their use | |
EP2130552A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-GRP78 ANTIBODY AS AN ACTIVE SUBSTANCE | |
IL177533A (en) | Benzimidazole derivatives, their preparation and pharmaceutical compositions comprising them | |
IL192967A0 (en) | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof | |
IL200206A (en) | The history of quinaxaline, their preparation and their pharmaceutical preparations | |
IL194546A0 (en) | Arylaminopyridine derivatives and pharmaceutical compositions containing them | |
EP2078731A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT | |
IL192826A0 (en) | Thiazole derivatives, their preparation and pharmaceutical compositions containing them | |
IL204844A (en) | Coinolone analogues, pharmaceuticals containing them and their uses | |
IL198301A (en) | Aryl amides are stored in thiazole and oxazole, a pharmaceutical preparation containing them and their use in the preparation of drugs | |
IL206808A (en) | Indolyl-pyridone history, their pharmaceutical preparations and their uses | |
EP2056835A4 (en) | PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | |
EP2199402A4 (en) | CYCLOASTRAGENOL MONOGLYCOSIDE, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF | |
ZA200900237B (en) | Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them | |
IL193211A (en) | Derivatives of Indzol-Troaril and pharmaceutical preparations containing them | |
EP2241569A4 (en) | THIENOPYRIDAZINE COMPOUNDS, PREPARATIONS THEREOF, PHARMACEUTICAL COMPOSITIONS AND USES |